---

layout: post
category: press
title: "Sight Diagnostics raises $71M Series D for its blood analyzer"
date: 2020-08-05 14:40:26
link: https://vrhk.co/3ifbVX5
image: https://techcrunch.com/wp-content/uploads/2020/08/OLO-solo.jpg?w=711
domain: techcrunch.com
author: "TechCrunch"
icon: https://techcrunch.com/wp-content/uploads/2015/02/cropped-cropped-favicon-gradient.png?w=180
excerpt: "Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led its Series C round)and crowd-funding platform OurCrowd…"

---

### Sight Diagnostics raises $71M Series D for its blood analyzer – TechCrunch

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which led its Series C round)and crowd-funding platform OurCrowd…